Technology | September 11, 2014

Elekta Knowledge Management Harnesses Cancer Data Through Advanced Analytics

September 11, 2014 — Elekta is showcasing its Elekta Knowledge Management software at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 14-17. The solution is a cloud-based, clinical and business intelligence software platform that allows healthcare providers to gain unprecedented and actionable insight from clinical, operational, financial and research data. Through advanced analytics, the platform enables the collection, integration, mining and analysis of comprehensive oncology data across the care continuum.

"Cancer therapy is more complex than ever before," said Todd Powell, executive vice president, Elekta Software. "The number of oncology patients has increased, the number of treatment options has multiplied and providers are being asked to do more with less. With Elekta Knowledge Management, we provide our customers with a superior oncology analytics platform that will provide useful, real-time information to accelerate clinical discovery, support personalized medicine and improve overall quality of cancer treatment."

Elekta's Knowledge Management applications include advanced healthcare analytics, dashboards and reports; specialized cancer and neurosurgery registries; and oncology imaging management solutions. Deployed on an integrated platform, these applications will ensure that critical data required to make informed decisions is available for the right patient, at the right time, for the right treatment.

A core application of Knowledge Management is the METRIQ cancer registry, which is used by 1,200 customers globally on a daily basis to aggregate data on cancer patients, diseases and treatments from disparate oncology electronic medical record (EMR) and health information technology (HIT) source systems. The high-quality data from METRIQ is also unique in that it is used to support epidemiological cancer studies to produce comprehensive and accurate information used for hospital, state and regional reporting on cancer outcomes.

"Cancer registry data isn't new, but most registries only provide new data every five years," said Shaun Costello, clinical director, Southern Cancer Network, Dunedin Hospital, New Zealand. "So, in essence, clinicians are using old data even as the treatment options for cancer are changing every day. Providing real-time data to our physicians is a significant improvement in clinical decision-making."

For more information: www.elekta.com/information-guided

Related Content

Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pan
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID-19 #COVID19 #Coronavirus #2019-nCoV

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | February 28, 2020
February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COV
Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center
News | Stereotactic Body Radiation Therapy (SBRT) | February 27, 2020
February 27, 2020 — Accuray Incorporated announced that Mercy
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...